The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature.
Diet therapy
Gastrointestinal microbiome
Kidney diseases
Nephrolithiasis
Systematic review
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
05 06 2020
05 06 2020
Historique:
received:
28
05
2019
accepted:
14
04
2020
entrez:
7
6
2020
pubmed:
7
6
2020
medline:
9
9
2021
Statut:
epublish
Résumé
There is mounting evidence that individuals with kidney disease and kidney stones have an abnormal gut microbiota composition. No studies to date have summarised the evidence to categorise how the gut microbiota profile of these individuals may differ from controls. Synthesis of this evidence is essential to inform future clinical trials. This systematic review aims to characterise differences of the gut microbial community in adults with kidney disease and kidney stones, as well as to describe the functional capacity of the gut microbiota and reporting of diet as a confounder in these studies. Included studies were those that investigated the gut microbial community in adults with kidney disease or kidney stones and compared this to the profile of controls. Six scientific databases (CINHAL, Medline, PubMed, Scopus, Web of Science and Cochrane Library), as well as selected grey literature sources, were searched. Quality assessment was undertaken independently by three authors. The system of evidence level criteria was employed to quantitatively evaluate the alteration of microbiota by strictly considering the number, methodological quality and consistency of the findings. Additional findings relating to altered functions of the gut microbiota, dietary intakes and dietary methodologies used were qualitatively summarised. Twenty-five articles met the eligibility criteria and included data from a total of 892 adults with kidney disease or kidney stones and 1400 controls. Compared to controls, adults with kidney disease had increased abundances of several microbes including Enterobacteriaceae, Streptococcaceae, Streptococcus and decreased abundances of Prevotellaceae, Prevotella, Prevotella 9 and Roseburia among other taxa. Adults with kidney stones also had an altered microbial composition with variations to Bacteroides, Lachnospiraceae NK4A136 group, Ruminiclostridium 5 group, Dorea, Enterobacter, Christensenellaceae and its genus Christensenellaceae R7 group. Differences in the functional potential of the microbial community between controls and adults with kidney disease or kidney stones were also identified. Only three of the 25 articles presented dietary data, and of these studies, only two used a valid dietary assessment method. The gut microbiota profile of adults with kidney disease and kidney stones differs from controls. Future study designs should include adequate reporting of important confounders such as dietary intake to assist with interpretation of findings.
Sections du résumé
BACKGROUND
There is mounting evidence that individuals with kidney disease and kidney stones have an abnormal gut microbiota composition. No studies to date have summarised the evidence to categorise how the gut microbiota profile of these individuals may differ from controls. Synthesis of this evidence is essential to inform future clinical trials. This systematic review aims to characterise differences of the gut microbial community in adults with kidney disease and kidney stones, as well as to describe the functional capacity of the gut microbiota and reporting of diet as a confounder in these studies.
METHODS
Included studies were those that investigated the gut microbial community in adults with kidney disease or kidney stones and compared this to the profile of controls. Six scientific databases (CINHAL, Medline, PubMed, Scopus, Web of Science and Cochrane Library), as well as selected grey literature sources, were searched. Quality assessment was undertaken independently by three authors. The system of evidence level criteria was employed to quantitatively evaluate the alteration of microbiota by strictly considering the number, methodological quality and consistency of the findings. Additional findings relating to altered functions of the gut microbiota, dietary intakes and dietary methodologies used were qualitatively summarised.
RESULTS
Twenty-five articles met the eligibility criteria and included data from a total of 892 adults with kidney disease or kidney stones and 1400 controls. Compared to controls, adults with kidney disease had increased abundances of several microbes including Enterobacteriaceae, Streptococcaceae, Streptococcus and decreased abundances of Prevotellaceae, Prevotella, Prevotella 9 and Roseburia among other taxa. Adults with kidney stones also had an altered microbial composition with variations to Bacteroides, Lachnospiraceae NK4A136 group, Ruminiclostridium 5 group, Dorea, Enterobacter, Christensenellaceae and its genus Christensenellaceae R7 group. Differences in the functional potential of the microbial community between controls and adults with kidney disease or kidney stones were also identified. Only three of the 25 articles presented dietary data, and of these studies, only two used a valid dietary assessment method.
CONCLUSIONS
The gut microbiota profile of adults with kidney disease and kidney stones differs from controls. Future study designs should include adequate reporting of important confounders such as dietary intake to assist with interpretation of findings.
Identifiants
pubmed: 32503496
doi: 10.1186/s12882-020-01805-w
pii: 10.1186/s12882-020-01805-w
pmc: PMC7275316
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
215Références
PLoS One. 2014 Jun 12;9(6):e99006
pubmed: 24922509
Medicine (Baltimore). 2018 Apr;97(15):e9862
pubmed: 29642227
Microbiologyopen. 2019 Apr;8(4):e00678
pubmed: 30088332
Clin Gastroenterol Hepatol. 2019 Jan;17(2):218-230
pubmed: 30240894
Transl Res. 2017 Jan;179:24-37
pubmed: 27187743
J Transl Med. 2019 Jul 17;17(1):228
pubmed: 31315634
Sci Rep. 2016 Oct 06;6:34712
pubmed: 27708409
Obesity (Silver Spring). 2017 Mar;25(3):497-498
pubmed: 28177586
J Inherit Metab Dis. 2018 May;41(3):379-391
pubmed: 28840392
Sci Rep. 2017 Nov 15;7(1):15601
pubmed: 29142271
Subcell Biochem. 2010;53:3-25
pubmed: 20593260
Microb Pathog. 2017 Aug;109:287-291
pubmed: 28624518
Trends Biotechnol. 2015 Sep;33(9):496-503
pubmed: 26210164
BMC Nephrol. 2014 Jun 09;15:87
pubmed: 24912660
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Genome Res. 2009 Jul;19(7):1141-52
pubmed: 19383763
Nephron Clin Pract. 2014;128(3-4):303-11
pubmed: 25531673
Sci Rep. 2017 May 3;7(1):1445
pubmed: 28469156
FEMS Yeast Res. 2006 Jan;6(1):40-7
pubmed: 16423069
BJU Int. 2020 Jan;125(1):133-143
pubmed: 31145528
Pain. 2003 Jul;104(1-2):303-22
pubmed: 12855341
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2015;33(1):36-66
pubmed: 25803195
J Nephropharmacol. 2013 Jul 01;2(2):37-43
pubmed: 28197445
Nat Rev Gastroenterol Hepatol. 2012 Mar 27;9(6):312-22
pubmed: 22450307
Antonie Van Leeuwenhoek. 2016 Oct;109(10):1389-96
pubmed: 27431681
Nutr Rev. 2017 Apr 1;75(4):286-305
pubmed: 28402523
Gut. 2018 Dec;67(12):2097-2106
pubmed: 29705728
Urolithiasis. 2016 Oct;44(5):399-407
pubmed: 27115405
J Caring Sci. 2018 Mar 01;7(1):17-20
pubmed: 29637052
Urolithiasis. 2018 Nov;46(6):503-514
pubmed: 29353409
Biomed Res Int. 2017;2017:5765417
pubmed: 28194419
Am J Kidney Dis. 2016 Mar;67(3):483-98
pubmed: 26590448
Biochem J. 2017 May 16;474(11):1823-1836
pubmed: 28512250
Cell. 2014 Mar 27;157(1):121-41
pubmed: 24679531
Cell Host Microbe. 2012 Oct 18;12(4):496-508
pubmed: 23084918
Kidney Int. 2013 Feb;83(2):308-15
pubmed: 22992469
Sci Rep. 2018 Nov 9;8(1):16598
pubmed: 30413731
Circ Res. 2015 Jan 30;116(3):448-55
pubmed: 25599331
Nutrients. 2017 May 12;9(5):
pubmed: 28498348
Am J Nephrol. 2015;42(4):305-17
pubmed: 26517816
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):223-31
pubmed: 26772193
BMJ. 2018 Jun 13;361:k2179
pubmed: 29899036
Am J Nephrol. 2014;39(3):230-237
pubmed: 24643131
Toxins (Basel). 2018 Apr 13;10(4):
pubmed: 29652797
Nan Fang Yi Ke Da Xue Xue Bao. 2018 Dec 30;38(12):1401-1408
pubmed: 30613005
Pediatr Nephrol. 2017 Nov;32(11):2005-2014
pubmed: 27848096
Front Microbiol. 2016 Feb 17;7:185
pubmed: 26925050
Adv Appl Microbiol. 2010;72:63-87
pubmed: 20602988
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):199-201
pubmed: 26772192
Acta Diabetol. 2019 May;56(5):581-592
pubmed: 30888537
PLoS Comput Biol. 2012;8(12):e1002808
pubmed: 23300406
Nature. 2012 Sep 13;489(7415):220-30
pubmed: 22972295
Eur J Cancer. 2005 Nov;41(17):2613-9
pubmed: 16226458
Annu Rev Food Sci Technol. 2018 Mar 25;9:65-84
pubmed: 29298101
Scand J Work Environ Health. 2000 Feb;26(1):7-19
pubmed: 10744172
Pathogens. 2013 Dec 06;2(4):636-52
pubmed: 25437337
Chin Med J (Engl). 2018 Dec 5;131(23):2792-2799
pubmed: 30511681
Nephrology (Carlton). 2012 Nov;17(8):733-8
pubmed: 22817644
Clin Transl Immunology. 2016 Jun 10;5(6):e86
pubmed: 27757226
PLoS One. 2015 Aug 04;10(8):e0134311
pubmed: 26241311
J Am Soc Nephrol. 2008 Jun;19(6):1197-203
pubmed: 18322162
Nephrology (Carlton). 2018 Oct;23 Suppl 4:16-20
pubmed: 30298666
Dig Dis Sci. 2014 Sep;59(9):2109-17
pubmed: 24828917
J Ren Nutr. 2018 Jan;28(1):28-36
pubmed: 28888762
Appl Environ Microbiol. 2012 Feb;78(4):1107-12
pubmed: 22179250
Pediatr Nephrol. 2017 Jun;32(6):921-931
pubmed: 27129691
Caspian J Intern Med. 2013 Spring;4(2):627-35
pubmed: 24009950
J Am Soc Nephrol. 2014 Apr;25(4):657-70
pubmed: 24231662
Adv Biochem Eng Biotechnol. 2001;73:31-52
pubmed: 11816811
Front Cell Infect Microbiol. 2019 Jun 12;9:206
pubmed: 31245306
Nephrol Dial Transplant. 2011 Mar;26(3):938-47
pubmed: 20884620
Int J Surg. 2016 Dec;36(Pt D):607-612
pubmed: 27847292
Sci Rep. 2017 Jun 6;7(1):2870
pubmed: 28588309
Adv Nutr. 2016 May 16;7(3):445-54
pubmed: 27184272
Kidney Int. 2013 Jun;83(6):1144-9
pubmed: 23536130
J Am Soc Nephrol. 2016 Nov;27(11):3479-3487
pubmed: 27230658
J Transl Med. 2017 Apr 8;15(1):73
pubmed: 28388917
Kidney Int. 2015 Nov;88(5):958-66
pubmed: 26376131
Biomed Res Int. 2017;2017:9351507
pubmed: 29230419
J Clin Med. 2017 Sep 19;6(9):
pubmed: 28925931
Int J Nephrol. 2012;2012:673631
pubmed: 23316359
Nat Microbiol. 2017 Apr 25;2:17026
pubmed: 28440278
Eur Urol. 2002 Mar;41(3):318-22
pubmed: 12180235